Vertaling van "osteoporotic fragility fractures in postmenopausal women " (Frans → Nederlands) :

49. NICE. Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.
hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.

Data on File. ii Siris SE at al Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to
Data on File. ii Siris SE at al Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and